Indevus/Pliva Sanctura For Overactive Bladder Clears FDA; Third Quarter Launch Planned
This article was originally published in The Pink Sheet Daily
Executive Summary
Indevus and Pliva will detail trospium with a sales force of approximately 480 reps under a co-promotion deal signed in April. The companies will face marketing powerhouses Pfizer (Detrol LA) and J&J (Ditropan XL).